"TumorID","BcatStatus","SAMPLE_INITIAL_WEIGHT","AGE","AJCC_PATHOLOGIC_TUMOR_STAGE","DFS_MONTHS","DFS_STATUS","HISTOLOGICAL_DIAGNOSIS","HISTORY_ADRENAL_HORMONE_EXCESS","OS_MONTHS","OS_STATUS","SEX","WEISS_SCORE_OVERALL","TP53Status","OS5years","Histotype","sampleId","studyId","CANCER_TYPE","CANCER_TYPE_DETAILED","DAYS_TO_COLLECTION","FRACTION_GENOME_ALTERED","IS_FFPE","MUTATION_COUNT","OCT_EMBEDDED","ONCOTREE_CODE","OTHER_SAMPLE_ID","PATHOLOGY_REPORT_FILE_NAME","PATHOLOGY_REPORT_UUID","SAMPLE_TYPE","SAMPLE_TYPE_ID","SOMATIC_STATUS","TMB_NONSYNONYMOUS","VIAL_NUMBER","ATYPICAL_MITOTIC_FIGURES","CAPSULAR_INVASION","CLIN_M_STAGE","CLINICAL_STATUS_WITHIN_3_MTHS_SURGERY","CT_SCAN_PREOP_RESULTS","CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT","DAYS_LAST_FOLLOWUP","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","DIFFUSE_ARCHITECTURE","ETHNICITY","FORM_COMPLETION_DATE","HISTORY_BASIS_ADRENAL_HORMONE_DX","HISTORY_NEOADJUVANT_TRTYN","HISTORY_OTHER_MALIGNANCY","ICD_10","ICD_O_3_HISTOLOGY","ICD_O_3_SITE","INFORMED_CONSENT_VERIFIED","INITIAL_PATHOLOGIC_DX_YEAR","LATERALITY","LYMPH_NODE_EXAMINED_COUNT","LYMPH_NODES_EXAMINED","LYMPH_NODES_EXAMINED_HE_COUNT","METASTATIC_DX_CONFIRMED_BY","METASTATIC_DX_CONFIRMED_BY_OTHER","METASTATIC_SITE_PATIENT","MITOSES_PER_50_HPF","MITOTIC_RATE","MOLECULAR_STUDIES_OTHERS_PERFORMED","NECROSIS","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","NUCLEAR_GRADE_III_IV","OTHER_PATIENT_ID","PATH_N_STAGE","PATH_T_STAGE","PHARM_TX_MITOTANE_ADJUVANT","PHARM_TX_MITOTANE_FOR_MACRO_DISEASE","PHARM_TX_MITOTANE_INDICATOR","PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG","PHARM_TX_MITOTANE_THERAPUTIC_AT_REC","PHARM_TX_MITOTANE_THERAPUTIC_LEVELS","PHARM_TX_MITOTANE_THERAPUTIC_MACRO","PHARMACEUTICAL_TX_ADJUVANT","PROSPECTIVE_COLLECTION","RACE","RADIATION_TREATMENT_ADJUVANT","RESIDUAL_TUMOR","RET","RETROSPECTIVE_COLLECTION","SAMPLE_COUNT","SINUSOID_INVASION","SITE_OF_TUMOR_TISSUE","TISSUE_SOURCE_SITE","TREATMENT_OUTCOME_FIRST_COURSE","TUMOR_STATUS","WEISS_VENOUS_INVASION","hugoGeneSymbol","proteinChange","keyword","gene_proteinChange","Annot_mut","TP53_CN","Annot_CN","HormoneExpression","OS_Status","OS_Months"
"TCGA-OR-A5J1","wt",40,58,"Stage II",24.77,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Mineralocorticoids",44.51,"1:DECEASED","Male",3,0,1,"ACC","TCGA-OR-A5J1-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4691,0.0585,"NO",39,TRUE,"ACC","E4038EBB-6E6D-44B1-84AD-E35AAFCA7B70","TCGA-OR-A5J1.8866FD87-4F6F-4D7E-B99A-7DD427ED3BB3.pdf","8866FD87-4F6F-4D7E-B99A-7DD427ED3BB3","Primary",1,"Matched",1.26666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0",NA,"[Unknown]","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","[Not Evaluated]","2014-4-2","[Unknown]","No","No","C74.0","8370/1","C74.0","YES",2000,"Left",NA,"[Unknown]",NA,NA,NA,NA,5,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","YES","Nuclear Grade III or IV Absent","B3164F7B-C826-4E08-9EE6-8FF96D29B913","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Mineralocorticoids",1,44.51
"TCGA-OR-A5J2",NA,350,44,"Stage IV",9.49,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen",55.09,"1:DECEASED","Female",8,1,1,"ACC","TCGA-OR-A5J2-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",3124,0.4033,"NO",81,TRUE,"ACC","46B7EB7C-E5F7-476D-A68C-5972F947445F","TCGA-OR-A5J2.345C34EE-F031-41A4-B955-BA054F2A3CE1.pdf","345C34EE-F031-41A4-B955-BA054F2A3CE1","Primary",1,"Matched",2.73333333333,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","HISPANIC OR LATINO","12/3/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2004,"Left",1,"YES",0,"Imaging Suspected",NA,"Lung",0,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","8E7C2E31-D085-4B75-A970-162526DD07A0","N0","T3",NA,"YES","YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present","TP53","H168Cfs*8","TP53 truncating","TP53, H168Cfs*8",1,0,0,"Androgen",1,55.09
"TCGA-OR-A5J3","wt",310,23,"Stage III",37.75,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",68.69,"0:LIVING","Female",6,0,0,"ACC","TCGA-OR-A5J3-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1584,0.4131,"NO",69,TRUE,"ACC","1FB59B6F-53C0-4B14-82CC-77CD55C67AD6","TCGA-OR-A5J3.83F53610-4F40-425B-9B69-BBB94234224F.pdf","83F53610-4F40-425B-9B69-BBB94234224F","Primary",1,"Matched",2.33333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1942,0,"Diffuse Architecture Present","HISPANIC OR LATINO","12/2/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2008,"Left",4,"YES",0,NA,NA,NA,6,"Mitotic Rate > 5/50 HPF Present","YES","Necrosis Present","YES","Nuclear Grade III or IV Present","DFD687BC-6E69-42F7-AF94-D17FC150D1A1","N0","T3","YES",NA,"YES",NA,"YES","YES",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,0,0,"Androgen+Cortisol",0,68.69
"TCGA-OR-A5J4",NA,80,23,"Stage IV",4.14,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",13.9,"1:DECEASED","Female",6,0,1,"ACC","TCGA-OR-A5J4-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4642,0.9259,"NO",171,TRUE,"ACC","51EE1274-9144-4464-AA1E-AD15D9086984","TCGA-OR-A5J4.39E300DC-C01F-46BC-AE4C-D834458F1FF7.pdf","39E300DC-C01F-46BC-AE4C-D834458F1FF7","Primary",1,"Matched",5.66666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Absent",NA,0,"Diffuse Architecture Present","HISPANIC OR LATINO","12/2/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2000,"Right",2,"YES",2,"Imaging Suspected",NA,"Lung",77,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","5F3E2974-F1DF-47A2-8A8A-29BB525EEEF6","N1","T3",NA,"YES","YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,1,0,"Androgen+Cortisol",1,13.9
"TCGA-OR-A5J5","ZNRF3_mut",40,30,"Stage III",1.64,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",11.99,"1:DECEASED","Male",6,1,1,"ACC","TCGA-OR-A5J5-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4537,0.8015,"NO",521,TRUE,"ACC","C6214F9B-35C8-424C-B6FE-BEC1A9317C0A","TCGA-OR-A5J5.BB63299C-B7F7-4F08-998D-C30E56CD6065.pdf","BB63299C-B7F7-4F08-998D-C30E56CD6065","Primary",1,"Matched",17.3666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","Persistent locoregional disease","YES","Cytoplasm presence <= 25% Absent",NA,0,"Diffuse Architecture Absent","HISPANIC OR LATINO","12/3/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2000,"Right",NA,"NO",NA,NA,NA,NA,3,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","802DBD0D-EF07-4C91-AB8D-1DD39532E947","N0","T4",NA,"YES","YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present","TP53","R273C","TP53 R273 missense","TP53, R273C",1,0,0,"None",1,11.99
"TCGA-OR-A5J6","wt",340,29,"Stage II",88.8,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",88.8,"0:LIVING","Female",3,0,0,"ACC","TCGA-OR-A5J6-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2220,0.4785,"NO",92,TRUE,"ACC","C0C9DD1B-98B1-4A20-8927-3C0B75A4559E","TCGA-OR-A5J6.F664D25E-9050-460D-AEAE-AA4BFA515453.pdf","F664D25E-9050-460D-AEAE-AA4BFA515453","Primary",1,"Matched",3.06666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",2428,0,"Diffuse Architecture Present","HISPANIC OR LATINO","12/3/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2006,"Right",NA,"NO",NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Present","YES","Necrosis Absent","NO","Nuclear Grade III or IV Absent","C8898B42-B704-45A0-9829-144B98F416E0","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","BLACK OR AFRICAN AMERICAN","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Androgen+Cortisol",0,88.8
"TCGA-OR-A5J7","wt",120,30,"Stage III",5.32,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",16.1,"1:DECEASED","Female",6,1,1,"ACC","TCGA-OR-A5J7-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1388,0.8933,"NO",91,TRUE,"ACC","945CC9B8-A732-484E-B423-9EFBC556E3FD","TCGA-OR-A5J7.F9C1971C-5BE2-4722-9A6C-CF4A4AD04352.pdf","F9C1971C-5BE2-4722-9A6C-CF4A4AD04352","Primary",1,"Matched",3.06666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Absent","HISPANIC OR LATINO","12/2/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2009,"Right",1,"YES",0,NA,NA,NA,3,"Mitotic Rate > 5/50 HPF Absent","YES","Necrosis Present","YES","Nuclear Grade III or IV Present","075DBFD0-9CF4-4877-884F-AE858902C79E","N0","T3","YES",NA,"YES",NA,NA,"NO",NA,"YES","NO","WHITE","NO","R1",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",1,16.1
"TCGA-OR-A5J8","wt",160,66,"Stage III",17.41,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",19.02,"1:DECEASED","Male",8,1,1,"ACC","TCGA-OR-A5J8-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",396,0.2528,"NO",159,TRUE,"ACC","2F47F06E-8F76-440E-BBCE-B7C90635A59E","TCGA-OR-A5J8.EA68CD7A-9308-40CD-BB52-CEB36334A146.pdf","EA68CD7A-9308-40CD-BB52-CEB36334A146","Primary",1,"Matched",5.3,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","HISPANIC OR LATINO","12/3/13","Biochemical Assessment","No","No","C74.0","8370/3","C74.0","YES",2011,"Left",1,"YES",0,NA,NA,NA,15,"Mitotic Rate > 5/50 HPF Present","YES","Necrosis Present","YES","Nuclear Grade III or IV Present","08E0D412-D4D8-4D13-B792-A4DD0BD9EC2B","N0","T3","YES",NA,"YES",NA,"NO","NO",NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","WITH TUMOR","Venous Invasion Present","TP53","T125=",NA,"TP53, T125=",1,1,0,"Cortisol",1,19.02
"TCGA-OR-A5J9","ZNRF3_mut",190,22,"Stage II",13.6,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",44.42,"0:LIVING","Female",6,0,0,"ACC","TCGA-OR-A5J9-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",849,0.9466,"NO",115,TRUE,"ACC","14D95372-5444-4525-B2D6-19FC51F3E336","TCGA-OR-A5J9.4C775CF4-39D7-4246-87A4-4659783A1C18.pdf","4C775CF4-39D7-4246-87A4-4659783A1C18","Primary",1,"Matched",3.86666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1183,0,"Diffuse Architecture Present","HISPANIC OR LATINO","12/3/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2010,"Right",NA,"NO",NA,NA,NA,NA,6,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","A53E9117-0A49-40D8-AF40-7867370B671A","N0","T2","YES",NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Complete Remission/Response","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,44.42
"TCGA-OR-A5JA","ZNRF3_mut",180,53,"Stage IV",NA,NA,"Adrenocortical carcinoma- Usual Type","Androgen",30.29,"1:DECEASED","Female",9,1,1,"ACC","TCGA-OR-A5JA-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2931,0.7904,"NO",618,TRUE,"ACC","292BCBE1-2FB7-4781-89DA-C33F4589E71B","TCGA-OR-A5JA.6A505565-429B-4D8A-A591-AAB54CF43B66.pdf","6A505565-429B-4D8A-A591-AAB54CF43B66","Primary",1,"Matched",20.4,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present",NA,"9/17/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2004,"Right",NA,"NO",NA,"Imaging Suspected",NA,"Lung|Liver|Other, specify",90,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","48402D61-3A6B-4603-BFA0-B1A38A47D34D","N0","T4",NA,NA,"NO",NA,NA,NA,NA,"YES","NO","WHITE","NO","R1",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Present","TP53","E56*","TP53 truncating","TP53, E56*",1,-1,1,"Androgen",1,30.29
"TCGA-OR-A5JA","ZNRF3_mut",180,53,"Stage IV",NA,NA,"Adrenocortical carcinoma- Usual Type","Androgen",30.29,"1:DECEASED","Female",9,1,1,"ACC","TCGA-OR-A5JA-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2931,0.7904,"NO",618,TRUE,"ACC","292BCBE1-2FB7-4781-89DA-C33F4589E71B","TCGA-OR-A5JA.6A505565-429B-4D8A-A591-AAB54CF43B66.pdf","6A505565-429B-4D8A-A591-AAB54CF43B66","Primary",1,"Matched",20.4,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present",NA,"9/17/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2004,"Right",NA,"NO",NA,"Imaging Suspected",NA,"Lung|Liver|Other, specify",90,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","48402D61-3A6B-4603-BFA0-B1A38A47D34D","N0","T4",NA,NA,"NO",NA,NA,NA,NA,"YES","NO","WHITE","NO","R1",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Present","TP53","X25_splice","TP53 truncating","TP53, X25_splice",1,-1,1,"Androgen",1,30.29
"TCGA-OR-A5JB","wt",20,52,"Stage IV",NA,NA,"Adrenocortical carcinoma- Usual Type","None",18.1,"1:DECEASED","Male",7,1,1,"ACC","TCGA-OR-A5JB-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4678,0.3372,"NO",341,TRUE,"ACC","0C98B45D-09A6-48A6-89BA-48BA7A2142D5","TCGA-OR-A5JB.81022A25-6D64-419D-9B97-22348E17ECEA.pdf","81022A25-6D64-419D-9B97-22348E17ECEA","Primary",1,"Matched",11.2,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Persistent distant metastases",NA,"Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present",NA,"9/17/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2000,"Right",NA,NA,NA,"Other, specify","excision of brain met","Other, specify",15,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present",NA,"Nuclear Grade III or IV Present","D63F2F1E-1970-445F-907B-23CF4D9EFD83","N0","T4",NA,NA,NA,NA,NA,NA,NA,NA,"NO","WHITE",NA,"R1",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR",NA,NA,"Venous Invasion Absent","TP53","Y234C","TP53 Y234 missense","TP53, Y234C",1,-1,1,"None",1,18.1
"TCGA-OR-A5JC","ZNRF3_mut",30,37,NA,NA,NA,"Adrenocortical carcinoma- Usual Type","Estrogen",57.49,"1:DECEASED","Male",8,1,1,"ACC","TCGA-OR-A5JC-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4331,0.6536,"NO",69,TRUE,"ACC","01C1AD9E-B440-4394-942F-6128CFCB77CF","TCGA-OR-A5JC.328B8F7A-8CEC-4670-A83F-B16AF53E74CE.pdf","328B8F7A-8CEC-4670-A83F-B16AF53E74CE","Primary",1,"Matched",2.3,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent",NA,NA,NA,"Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present",NA,"9/17/13","Biochemical Assessment","No","No","C74.0","8370/3","C74.0","YES",2001,"Left",NA,"NO",NA,NA,NA,NA,24,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present",NA,"Nuclear Grade III or IV Present","BDFCD747-F6A2-42E2-BC9B-483112205FA8",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NO","WHITE",NA,NA,NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,NA,"Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Estrogen",1,57.49
"TCGA-OR-A5JD","wt",40,57,"Stage II",99.8,"0:DiseaseFree","Adrenocortical Carcinoma- Oncocytic Type","None",99.8,"0:LIVING","Female",3,0,0,"ACC","TCGA-OR-A5JD-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2571,0.9477,"NO",59,TRUE,"ACC","EE0849DC-0E32-446C-8E3E-49D395690EB4","TCGA-OR-A5JD.AA05D1FB-38B5-4D96-B9EE-07523C95C481.pdf","AA05D1FB-38B5-4D96-B9EE-07523C95C481","Primary",1,"Matched",1.93333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0",NA,NA,"Cytoplasm presence <= 25% Present",2782,0,"Diffuse Architecture Present",NA,"9/17/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2005,"Left",NA,NA,NA,NA,NA,NA,4,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent",NA,"Nuclear Grade III or IV Present","240DCA72-76E0-4D57-978D-1242E6E7ED68","N0","T2",NA,NA,NA,NA,NA,NA,NA,NA,"NO","WHITE",NA,"R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,99.8
"TCGA-OR-A5JE","wt",50,17,"Stage I",15.67,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",69.15,"1:DECEASED","Female",8,1,0,"ACC","TCGA-OR-A5JE-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2703,0.491,"NO",115,TRUE,"ACC","2AC53C7F-290C-4170-A102-F4BDB906F3F5","TCGA-OR-A5JE.80EDB29A-262A-486D-B31A-EA015FA8A362.pdf","80EDB29A-262A-486D-B31A-EA015FA8A362","Primary",1,"Matched",3.8,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0",NA,NA,"Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present",NA,"9/17/13","Biochemical Assessment","No","No","C74.0","8370/3","C74.0","YES",2005,"Left",NA,NA,NA,NA,NA,NA,60,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","BAFE2638-4ADC-4957-9D62-D7EEBE5DD2F9","N0","T1","YES",NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,-1,1,"Cortisol",1,69.15
"TCGA-OR-A5JF","ZNRF3_mut",30,69,"Stage II",66.2,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Cortisol",66.2,"0:LIVING","Female",4,0,0,"ACC","TCGA-OR-A5JF-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1908,0.9014,"NO",121,TRUE,"ACC","90F61EDA-6C83-48BA-87E0-2FE89BBFF03E","TCGA-OR-A5JF.D9851FF2-70AC-45AD-AF18-B8A4B9F01E17.pdf","D9851FF2-70AC-45AD-AF18-B8A4B9F01E17","Primary",1,"Matched",4,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease",NA,"Cytoplasm presence <= 25% Present",1259,0,"Diffuse Architecture Absent",NA,"10/3/13","Biochemical Assessment","No","No","C74.0","8370/3","C74.0","YES",2007,"Left",NA,NA,NA,NA,NA,NA,4,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent",NA,"Nuclear Grade III or IV Present","DAFB9844-1A5C-4AF8-B382-59C751942BB8","N0","T2","YES",NA,"YES",NA,NA,"YES",NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Cortisol",0,66.2
"TCGA-OR-A5JG","wt",60,61,"Stage IV",NA,NA,"Adrenocortical carcinoma- Usual Type","Cortisol",17.77,"1:DECEASED","Male",9,1,1,"ACC","TCGA-OR-A5JG-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1771,0.678,"NO",113,TRUE,"ACC","6D3146BA-8068-4DA5-BAAF-33C6946F138F","TCGA-OR-A5JG.15F6D8D6-878A-410F-8289-D3CEAB7E5D21.pdf","15F6D8D6-878A-410F-8289-D3CEAB7E5D21","Primary",1,"Matched",3.76666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present",NA,"10/3/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2008,"Left",8,"YES",6,NA,NA,"Other, specify",100,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present",NA,"Nuclear Grade III or IV Present","71892706-F8B6-44E6-8DE4-6CBB43F612E0","N1","T4",NA,NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE",NA,"R1",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Present","TP53","X125_splice","TP53 truncating","TP53, X125_splice",1,-1,1,"Cortisol",1,17.77
"TCGA-OR-A5JH",NA,20,32,"Stage II",69.32,"0:DiseaseFree","Adrenocortical Carcinoma- Oncocytic Type","None",69.32,"0:LIVING","Female",4,1,0,"ACC","TCGA-OR-A5JH-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1811,0.594,"NO",45,TRUE,"ACC","5DFDD66B-E079-4B5A-959E-A5558836D2F7","TCGA-OR-A5JH.CF498A30-11FC-4F20-A424-E3A1216D54B2.pdf","CF498A30-11FC-4F20-A424-E3A1216D54B2","Primary",1,"Matched",1.5,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1227,0,"Diffuse Architecture Present",NA,"2/6/14",NA,"No","No","C74.0","8370/3","C74.0","YES",2008,"Left",NA,NA,NA,NA,NA,NA,1,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present",NA,"Nuclear Grade III or IV Present","4F845FEA-E823-47D6-89FB-36EE478A43B8","N0","T2",NA,NA,NA,NA,NA,NA,NA,NA,"NO","WHITE",NA,"R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,-1,1,"None",0,69.32
"TCGA-OR-A5JI","wt",20,22,"Stage I",76.58,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",76.58,"0:LIVING","Male",3,0,0,"ACC","TCGA-OR-A5JI-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1499,0.4828,"NO",57,TRUE,"ACC","24C2E7DC-0162-4012-8ADD-A252FF535F9C","TCGA-OR-A5JI.F18AFE4B-5333-418A-A6D0-E347ACA3C06B.pdf","F18AFE4B-5333-418A-A6D0-E347ACA3C06B","Primary",1,"Matched",1.93333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1424,0,"Diffuse Architecture Present",NA,"9/18/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2008,"Right",NA,"NO",NA,NA,NA,NA,1,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent","NO","Nuclear Grade III or IV Present","B7ADB786-1F81-43CA-AC72-7243966CD439","N0","T1",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,76.58
"TCGA-OR-A5JJ","CTNNB1_mut",40,65,"Stage IV",NA,NA,"Adrenocortical carcinoma- Usual Type","None",16.1,"1:DECEASED","Male",9,1,1,"ACC","TCGA-OR-A5JJ-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1308,0.9476,"NO",84,TRUE,"ACC","0BE64816-8299-49B2-B96C-CD0F4DA7D37B","TCGA-OR-A5JJ.AF7A85AB-4C73-40B8-B913-9E540FEDE0FC.pdf","AF7A85AB-4C73-40B8-B913-9E540FEDE0FC","Primary",1,"Matched",2.8,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",309,0,"Diffuse Architecture Present",NA,"10/3/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2009,"Left",6,"YES",6,NA,NA,"Lung",50,"Mitotic Rate > 5/50 HPF Present","YES","Necrosis Present",NA,"Nuclear Grade III or IV Present","9EC86C06-E7A9-4EA6-B36D-6F832909054B","N1","T4",NA,NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Present","TP53","C275S","TP53 C275 missense","TP53, C275S",1,-2,1,"None",1,16.1
"TCGA-OR-A5JK","ZNRF3_mut",60,49,"Stage IV",49.18,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",49.18,"0:LIVING","Male",8,1,0,"ACC","TCGA-OR-A5JK-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1301,0.8746,"NO",74,TRUE,"ACC","6EEBC241-9E55-4520-BB4E-73E20D25726B","TCGA-OR-A5JK.69DBF44F-F313-423E-8DD7-E3F80AE875B8.pdf","69DBF44F-F313-423E-8DD7-E3F80AE875B8","Primary",1,"Matched",2.56666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",1255,0,"Diffuse Architecture Present",NA,"10/3/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2009,"Left",NA,NA,NA,"Biopsy Proven",NA,"Lung",4,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","A477B55D-A591-482F-A554-D8EF7298C23D","N0","T4",NA,NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","YES","R2",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"None",0,49.18
"TCGA-OR-A5JL","wt",60,36,"Stage I",67.54,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen",67.54,"0:LIVING","Female",5,1,0,"ACC","TCGA-OR-A5JL-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1224,0.8711,"NO",73,TRUE,"ACC","91FA4F80-0838-4A7B-9943-35221D440E9D","TCGA-OR-A5JL.BD8435C3-C525-472C-8B43-EC2CAE22B785.pdf","BD8435C3-C525-472C-8B43-EC2CAE22B785","Primary",1,"Matched",2.4,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",670,0,"Diffuse Architecture Present",NA,"9/18/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2009,"Right",NA,"NO",NA,NA,NA,NA,6,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Absent","NO","Nuclear Grade III or IV Present","0ACC28BC-D348-41DF-8F49-BC0332EB9BE4","N0","T1","YES",NA,"YES",NA,NA,"YES",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent","TP53","R335Lfs*10","TP53 truncating","TP53, R335Lfs*10",1,0,0,"Androgen",0,67.54
"TCGA-OR-A5JM","CTNNB1_mut",70,25,"Stage IV",2.37,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",18.46,"1:DECEASED","Female",9,1,1,"ACC","TCGA-OR-A5JM-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",657,0.4659,"NO",122,TRUE,"ACC","9D9ED7F5-8811-4EAD-A43D-52EF748B95B3","TCGA-OR-A5JM.A214150E-54BD-499D-A56D-082BAC861668.pdf","A214150E-54BD-499D-A56D-082BAC861668","Primary",1,"Matched",4,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Biochemical Evidence of Disease","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present",NA,"10/3/13","Both Clinical and Biochemical Assessments","Yes","No","C74.0","8370/3","C74.0","YES",2011,"Left",NA,NA,NA,"Other, specify",NA,"Liver",90,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","FB54458D-C373-46C2-841E-82663E13EFAA","N0","T4","YES",NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","YES","R1",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Cortisol",1,18.46
"TCGA-OR-A5JO","wt",20,26,"Stage I",39.22,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",39.22,"0:LIVING","Female",3,0,0,"ACC","TCGA-OR-A5JO-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2773,0,"NO",93,TRUE,"ACC","2D1788C4-196F-48C3-B0EC-E3F8DE351607","TCGA-OR-A5JO.1FECADEA-0B65-451D-933D-2217F9119D35.pdf","1FECADEA-0B65-451D-933D-2217F9119D35","Primary",1,"Matched",3.13333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Absent",889,0,"Diffuse Architecture Present",NA,"9/18/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2005,"Right",NA,"NO",NA,NA,NA,NA,2,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent","NO","Nuclear Grade III or IV Present","4FBBBE43-3C0E-4475-BCF8-3745BD7195EB","N0","T1",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,0,0,"None",0,39.22
"TCGA-OR-A5JP","wt",60,40,"Stage II",15.24,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",15.24,"0:LIVING","Male",6,1,0,"ACC","TCGA-OR-A5JP-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",289,0.4817,"NO",135,TRUE,"ACC","1A580A44-6D1A-4DF5-8DF5-F6BB0B328E68","TCGA-OR-A5JP.E7B0A3CF-35A3-433C-AF76-DB3E28DA6A46.pdf","E7B0A3CF-35A3-433C-AF76-DB3E28DA6A46","Primary",1,"Matched",4.43333333333,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",149,0,"Diffuse Architecture Present",NA,"4/2/14",NA,"No","No","C74.0","8370/3","C74.0","YES",2012,"Left",NA,"NO",NA,NA,NA,NA,13,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","0B73CBBA-5520-4610-B649-912D76114033","N0","T2","YES",NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent","TP53","E339Afs*8","TP53 truncating","TP53, E339Afs*8",1,-1,1,"None",0,15.24
"TCGA-OR-A5JQ","wt",40,26,"Stage II",36.24,"0:DiseaseFree","Adrenocortical Carcinoma- Myxoid Type","None",36.24,"0:LIVING","Female",4,0,0,"ACC","TCGA-OR-A5JQ-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2520,0.9014,"NO",56,TRUE,"ACC","98650D6C-1EAE-4A75-9AFC-7785229E1D99","TCGA-OR-A5JQ.3AE0E638-5907-4B56-9C55-E58D97B27AFF.pdf","3AE0E638-5907-4B56-9C55-E58D97B27AFF","Primary",1,"Matched",1.86666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",674,0,"Diffuse Architecture Present",NA,"9/18/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2006,"Right",NA,"NO",NA,NA,NA,NA,3,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent","NO","Nuclear Grade III or IV Present","199560CB-15E5-4276-865A-7D44D47C856C","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,1,0,"None",0,36.24
"TCGA-OR-A5JR","wt",80,45,"Stage I",121.16,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",121.16,"0:LIVING","Male",NA,0,0,"ACC","TCGA-OR-A5JR-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",3751,0.8612,"NO",45,FALSE,"ACC","EC87C3B6-2C8B-4C01-BAAA-9E6F01F44AC1","TCGA-OR-A5JR.33E0DEF4-2538-4C8B-A71C-11B4F9D57E32.pdf","33E0DEF4-2538-4C8B-A71C-11B4F9D57E32","Primary",1,"Matched",1.5,"A",NA,"Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES",NA,3688,0,"Diffuse Architecture Absent",NA,"9/9/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2002,"Left",NA,"NO",NA,NA,NA,NA,NA,NA,"YES","Necrosis Absent","NO","Nuclear Grade III or IV Absent","A19104D6-B6A6-4878-AF2C-783679070A05","N0","T1",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,121.16
"TCGA-OR-A5JS","CTNNB1_mut",150,65,"Stage II",5.45,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",12.58,"0:LIVING","Female",NA,0,0,"ACC","TCGA-OR-A5JS-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",699,0.5758,"NO",127,FALSE,"ACC","693578FD-91D0-447E-BA98-DCAABEC8B4DB","TCGA-OR-A5JS.B6E65697-5AE8-45B4-9FAA-D25B8F57988F.pdf","B6E65697-5AE8-45B4-9FAA-D25B8F57988F","Primary",1,"Matched",4.23333333333,"A",NA,"Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES",NA,383,0,NA,NA,"9/9/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2011,"Right",NA,"NO",NA,NA,NA,NA,35,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES",NA,"82940E94-AC74-4A9B-9DA5-9E4B7D4D45C0","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","YES","R0",NA,"YES",1,NA,"Adrenal","OR",NA,"WITH TUMOR",NA,NA,NA,NA,NA,0,0,0,"None",0,12.58
"TCGA-OR-A5JT","wt",140,65,"Stage II",29.8,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Cortisol",29.8,"0:LIVING","Female",NA,0,0,"ACC","TCGA-OR-A5JT-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",419,0.8937,"NO",68,FALSE,"ACC","EBED7059-064A-4785-A6DD-A8C29486FE7A","TCGA-OR-A5JT.095AE671-9808-4895-B6FD-EDA3F7F9E69D.pdf","095AE671-9808-4895-B6FD-EDA3F7F9E69D","Primary",1,"Matched",2.3,"A",NA,"Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES",NA,488,0,NA,NA,"9/9/13","Biochemical Assessment","No","No","C74.0","8370/3","C74.0","YES",2011,"Left",17,"YES",0,NA,NA,NA,5,"Mitotic Rate > 5/50 HPF Absent","YES","Necrosis Present","NO",NA,"C0E1A036-BE4C-4FB5-BB50-E2431BE60ED4","N0","T2","YES",NA,"YES",NA,"YES","YES",NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,NA,"Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Cortisol",0,29.8
"TCGA-OR-A5JU",NA,130,58,"Stage III",8.8,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",9.49,"1:DECEASED","Female",NA,0,1,"ACC","TCGA-OR-A5JU-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",749,2e-04,"NO",95,FALSE,"ACC","CC20EF21-77BE-49F3-8CC5-CAC498FE57F3","TCGA-OR-A5JU.2D791779-66E6-408C-B479-CC74246F0EA8.pdf","2D791779-66E6-408C-B479-CC74246F0EA8","Primary",1,"Matched",3.16666666667,"A",NA,"Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES",NA,NA,0,NA,NA,"2/6/14",NA,"No","No","C74.0","8370/3","C74.0","YES",2010,"Right",NA,"NO",NA,NA,NA,NA,10,"Mitotic Rate > 5/50 HPF Present","YES","Necrosis Absent","YES",NA,"CAC8EABA-9E40-4048-B8CC-87574F048D91","N0","T3","YES","NO","YES",NA,NA,NA,NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,NA,"Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",1,9.49
"TCGA-OR-A5JV","wt",110,55,"Stage II",31.31,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",66.46,"0:LIVING","Male",NA,1,0,"ACC","TCGA-OR-A5JV-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1696,0.5878,"NO",55,FALSE,"ACC","19B13418-64A4-438B-8BA6-2B04F11FC9A5","TCGA-OR-A5JV.35A41AE5-44E3-45D1-A2C0-523496732A75.pdf","35A41AE5-44E3-45D1-A2C0-523496732A75","Primary",1,"Matched",1.76666666667,"A",NA,"Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES",NA,1541,0,NA,NA,"9/9/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2008,"Left",1,"YES",0,NA,NA,NA,NA,NA,NA,"Necrosis Absent","YES",NA,"388B8788-A635-4BC9-9B73-D204B2256747","N0","T2","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,-1,1,"None",0,66.46
"TCGA-OR-A5JW","ZNRF3_mut",140,47,"Stage II",72.34,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Cortisol",72.34,"0:LIVING","Male",NA,1,0,"ACC","TCGA-OR-A5JW-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1713,0.9476,"NO",88,FALSE,"ACC","314F45AF-668C-4E36-9290-F8661B9258C7","TCGA-OR-A5JW.54BAF12C-F096-4415-BFF0-DD35D22E932B.pdf","54BAF12C-F096-4415-BFF0-DD35D22E932B","Primary",1,"Matched",2.9,"A",NA,NA,"M0","No imaging evidence of disease","YES",NA,1924,0,NA,NA,"9/9/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2008,"Right",NA,"NO",NA,NA,NA,NA,NA,NA,NA,"Necrosis Present","NO",NA,"63B7B596-CB55-41DC-B862-A6C3A058DFE2","N0","T2","YES",NA,"YES",NA,NA,"YES",NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,NA,"Adrenal","OR",NA,"TUMOR FREE",NA,NA,NA,NA,NA,0,-1,1,"Cortisol",0,72.34
"TCGA-OR-A5JX","wt",120,50,"Stage III",31.21,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",31.21,"0:LIVING","Male",NA,0,0,"ACC","TCGA-OR-A5JX-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1162,0.5957,"NO",90,FALSE,"ACC","F7FD9793-2825-44F4-B265-FAE7178AE49F","TCGA-OR-A5JX.6F548B5E-C4A2-46C7-8B56-7DD037CC49B5.pdf","6F548B5E-C4A2-46C7-8B56-7DD037CC49B5","Primary",1,"Matched",3,"A",NA,"Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES",NA,950,0,NA,NA,"9/10/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2009,"Left",1,"YES",0,NA,NA,NA,5,"Mitotic Rate > 5/50 HPF Absent","YES","Necrosis Present","NO",NA,"42F69B2B-F3AA-4F4E-AC3A-149E14789927","N0","T3","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,NA,"Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,0,0,"None",0,31.21
"TCGA-OR-A5JY","CTNNB1_mut",190,68,"Stage IV",3.65,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",18.13,"1:DECEASED","Female",NA,1,1,"ACC","TCGA-OR-A5JY-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",414,0.6017,"NO",119,FALSE,"ACC","2C8D4883-588E-441E-B20C-6208346D1F23","TCGA-OR-A5JY.8D4E0E4D-9C84-4F29-AFD9-91EEEC158ED6.pdf","8D4E0E4D-9C84-4F29-AFD9-91EEEC158ED6","Primary",1,"Matched",3.93333333333,"A",NA,"Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES",NA,NA,0,NA,NA,"9/10/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2011,"Right",2,"YES",1,"Other, specify","surgical resection","Liver",60,"Mitotic Rate > 5/50 HPF Present",NA,"Necrosis Present","YES",NA,"344F7EA4-2BD4-4F2D-89F2-9FC7F572A3D6","N1","T4","NO","YES","YES",NA,NA,NA,"NO","YES","NO","WHITE","YES","R2",NA,"YES",1,NA,"Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",1,18.13
"TCGA-OR-A5JZ","wt",130,60,"Stage II",8.11,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",27,"0:LIVING","Male",NA,0,0,"ACC","TCGA-OR-A5JZ-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",373,0.2367,"NO",73,FALSE,"ACC","83437041-D9DD-45A6-A0AC-17307FFB9513","TCGA-OR-A5JZ.90A9556D-C417-4FDB-AE1C-7ACB9F60E444.pdf","90A9556D-C417-4FDB-AE1C-7ACB9F60E444","Primary",1,"Matched",2.43333333333,"A",NA,"Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES",NA,211,0,NA,NA,"9/10/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2011,"Left",NA,"NO",NA,NA,NA,NA,5,"Mitotic Rate > 5/50 HPF Absent","YES","Necrosis Present","NO",NA,"94CDAC79-2B4E-483A-8F17-3E0C9BE589D0","N0","T2","YES",NA,"YES",NA,NA,"NO",NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,NA,"Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,27
"TCGA-OR-A5K0","wt",200,69,"Stage II",21.65,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",33.8,"0:LIVING","Female",NA,0,0,"ACC","TCGA-OR-A5K0-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1097,0.282,"NO",127,FALSE,"ACC","1E6B9FC4-3FED-4D32-89B8-AA15FB4A5840","TCGA-OR-A5K0.4E5C6CF0-F346-4ECE-B296-0D2DB4513804.pdf","4E5C6CF0-F346-4ECE-B296-0D2DB4513804","Primary",1,"Matched",4.2,"A",NA,"Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES",NA,1029,0,NA,NA,"9/16/13","Biochemical Assessment","No","Yes","C74.0","8370/3","C74.0","YES",2009,"Left",NA,"NO",NA,NA,NA,NA,8,"Mitotic Rate > 5/50 HPF Present",NA,"Necrosis Present","YES",NA,"EDC62C30-CACC-457D-96BA-D05ED35432A3","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Cortisol",0,33.8
"TCGA-OR-A5K1","wt",150,48,"Stage II",27.14,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",108.05,"0:LIVING","Male",NA,0,0,"ACC","TCGA-OR-A5K1-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2513,0.7253,"NO",85,FALSE,"ACC","C5F36CF1-4C1D-4633-BD0A-5E7F47CE7374","TCGA-OR-A5K1.54EFE89F-32E0-4E95-A841-728648D9D11E.pdf","54EFE89F-32E0-4E95-A841-728648D9D11E","Primary",1,"Matched",2.86666666667,"A",NA,"Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES",NA,2723,0,NA,NA,"9/10/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2006,"Left",NA,"NO",NA,NA,NA,NA,NA,NA,NA,NA,"YES",NA,"F8E77BB6-E521-4A6A-9CB4-4B58EE38CA7F","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","RX",NA,"YES",1,NA,"Adrenal","OR","Complete Remission/Response","TUMOR FREE",NA,NA,NA,NA,NA,0,0,0,"None",0,108.05
"TCGA-OR-A5K2","ZNRF3_mut",150,32,"Stage III",3.19,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",32.65,"1:DECEASED","Female",NA,1,1,"ACC","TCGA-OR-A5K2-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",810,0.3327,"NO",123,FALSE,"ACC","9DDAA508-3D15-4751-AB0F-69E4D8218FB3","TCGA-OR-A5K2.F6CEA42D-A107-4942-B6FE-1C529D124337.pdf","F6CEA42D-A107-4942-B6FE-1C529D124337","Primary",1,"Matched",4.16666666667,"A",NA,"Invasion of Tumor Capsule Present","M0","Persistent distant metastases","YES",NA,NA,0,NA,NA,"9/10/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2010,"Right",1,"YES",0,"Imaging Suspected",NA,"Lung",51,"Mitotic Rate > 5/50 HPF Present","YES","Necrosis Present","YES",NA,"6D980941-219E-40A0-9B41-E84C3FB0BD1A","N0","T4","YES","YES","YES",NA,"NO","YES",NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,NA,"Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",1,32.65
"TCGA-OR-A5K3","wt",110,53,"Stage II",113.83,"0:DiseaseFree","Adrenocortical Carcinoma- Oncocytic Type","None",113.83,"0:LIVING","Male",NA,0,0,"ACC","TCGA-OR-A5K3-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2646,0.5714,"NO",138,FALSE,"ACC","0727128A-84D8-47B9-A5F3-1F1EFF18F185","TCGA-OR-A5K3.718C16E9-A099-4F21-A48E-A97B464A9422.pdf","718C16E9-A099-4F21-A48E-A97B464A9422","Primary",1,"Matched",4.6,"A",NA,"Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES",NA,2842,0,NA,NA,"9/11/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2005,"Left",NA,"NO",NA,NA,NA,NA,NA,NA,"NO","Necrosis Present","NO",NA,"C72B973B-4719-46AB-AC99-05D14088D3BC","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR","Complete Remission/Response","TUMOR FREE",NA,NA,NA,NA,NA,0,0,0,"None",0,113.83
"TCGA-OR-A5K4","wt",190,64,"Stage III",35.55,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",35.55,"0:LIVING","Female",NA,1,0,"ACC","TCGA-OR-A5K4-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",362,0.8904,"NO",282,FALSE,"ACC","D35F621F-8426-43E7-B1BF-F670E46C7FA6","TCGA-OR-A5K4.15A731FD-6B89-450D-A02B-A01DA759340A.pdf","15A731FD-6B89-450D-A02B-A01DA759340A","Primary",1,"Matched",9.4,"A",NA,"Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES",NA,528,0,NA,NA,"9/11/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2011,"Right",NA,"NO",NA,NA,NA,NA,2,"Mitotic Rate > 5/50 HPF Absent","YES","Necrosis Present","NO",NA,"70F1569E-F8F5-4F1D-BF18-D0586B29077D","N0","T4","YES",NA,"YES",NA,NA,"NO",NA,"YES","NO","WHITE","YES","R1",NA,"YES",1,NA,"Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Present","TP53","R337H","TP53 R337 missense","TP53, R337H",1,0,0,"None",0,35.55
"TCGA-OR-A5K5","CTNNB1_mut",120,59,"Stage III",3.55,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",16.36,"1:DECEASED","Female",NA,1,1,"ACC","TCGA-OR-A5K5-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",34,0.5451,"NO",181,FALSE,"ACC","5101736C-1FF9-40D4-A57D-5B660C2B4D1F","TCGA-OR-A5K5.6EA3FB77-3DD4-43C8-8C39-CA8755EBC50C.pdf","6EA3FB77-3DD4-43C8-8C39-CA8755EBC50C","Primary",1,"Matched",5.96666666667,"A",NA,"Invasion of Tumor Capsule Present","M0",NA,"YES",NA,253,0,NA,NA,"9/11/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2012,"Left",20,"YES",0,NA,NA,NA,31,"Mitotic Rate > 5/50 HPF Present","YES","Necrosis Present","YES",NA,"CF332DAA-F335-4AF1-81DE-CBFDAFB0F764","N0","T3","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","YES","R0",NA,"YES",1,NA,"Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",1,16.36
"TCGA-OR-A5K6",NA,120,56,"Stage II",12.84,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",49.05,"0:LIVING","Female",5,0,0,"ACC","TCGA-OR-A5K6-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",946,0.1386,"NO",98,FALSE,"ACC","61884223-9CC2-4C14-8A73-6E1B6FBA3670","TCGA-OR-A5K6.CB9B68D7-762B-4828-9479-4ECFE346AB5C.pdf","CB9B68D7-762B-4828-9479-4ECFE346AB5C","Primary",1,"Matched",3.23333333333,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1130,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","10/8/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2010,"Left",NA,"NO",NA,NA,NA,NA,7,"Mitotic Rate > 5/50 HPF Present",NA,"Necrosis Present","YES","Nuclear Grade III or IV Present","28153E3E-8515-4852-AAA0-247F86399F27","N0","T2",NA,"YES","YES","YES",NA,NA,"YES","YES","YES","WHITE","NO","R0",NA,"NO",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Cortisol",0,49.05
"TCGA-OR-A5K8","wt",590,39,"Stage II",24.61,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Cortisol",24.61,"0:LIVING","Male",4,0,0,"ACC","TCGA-OR-A5K8-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",260,0.9477,"NO",81,TRUE,"ACC","E346DE66-4EDB-44EB-B363-3C02BEAC8635","TCGA-OR-A5K8.1C0D3231-1F36-4645-95D2-C6BFF78734C9.pdf","1C0D3231-1F36-4645-95D2-C6BFF78734C9","Primary",1,"Matched",2.7,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Absent",504,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","10/8/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2012,"Right",NA,"NO",NA,NA,NA,NA,7,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Absent","NO","Nuclear Grade III or IV Present","1AE9CD13-73EF-4B1A-A734-4C465C73BC8E","N0","T2","YES","NO","YES",NA,NA,"NO",NA,"YES","YES","WHITE","NO","R0",NA,"NO",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Cortisol",0,24.61
"TCGA-OR-A5K9","CTNNB1_mut",130,61,"Stage II",7.75,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",11.3,"1:DECEASED","Female",NA,1,1,"ACC","TCGA-OR-A5K9-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",3864,0.4184,"NO",205,FALSE,"ACC","E78F3AC4-0E3A-4DF8-873A-B7AB384CAF62","TCGA-OR-A5K9.EAC92541-2274-4FB8-B56B-657413EDF0F9.pdf","EAC92541-2274-4FB8-B56B-657413EDF0F9","Primary",1,"Matched",6.83333333333,"A",NA,NA,"M0","No imaging evidence of disease","YES",NA,NA,0,NA,NA,"9/11/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2002,"Right",NA,"NO",NA,NA,NA,NA,NA,NA,NA,NA,"YES",NA,"D890CBF7-41D8-4992-99C2-24C60C77B156","N0","T2","YES",NA,"YES",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR",NA,"WITH TUMOR",NA,NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",1,11.3
"TCGA-OR-A5KB",NA,60,61,"Stage II",7.03,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",24.34,"0:LIVING","Female",7,1,0,"ACC","TCGA-OR-A5KB-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",355,0.623,"NO",1990,TRUE,"ACC","FC29B5B8-0E57-4FA7-B9FE-69C5A0B1D83F","TCGA-OR-A5KB.7553DC0B-FD8C-42E9-B38F-65EA954C6BC6.pdf","7553DC0B-FD8C-42E9-B38F-65EA954C6BC6","Primary",1,"Matched",65.8666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Absent",741,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","5/8/14",NA,"No","No","C74.0","8370/3","C74.0","YES",2011,"Left",3,"YES",0,NA,NA,NA,129,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","09454ED6-64BC-4A35-AF44-7C4344623D45","N0","T2","YES",NA,"YES",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present","TP53","V173L","TP53 V173 missense","TP53, V173L",1,0,0,"None",0,24.34
"TCGA-OR-A5KB",NA,60,61,"Stage II",7.03,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",24.34,"0:LIVING","Female",7,1,0,"ACC","TCGA-OR-A5KB-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",355,0.623,"NO",1990,TRUE,"ACC","FC29B5B8-0E57-4FA7-B9FE-69C5A0B1D83F","TCGA-OR-A5KB.7553DC0B-FD8C-42E9-B38F-65EA954C6BC6.pdf","7553DC0B-FD8C-42E9-B38F-65EA954C6BC6","Primary",1,"Matched",65.8666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Absent",741,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","5/8/14",NA,"No","No","C74.0","8370/3","C74.0","YES",2011,"Left",3,"YES",0,NA,NA,NA,129,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","09454ED6-64BC-4A35-AF44-7C4344623D45","N0","T2","YES",NA,"YES",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present","TP53","K132N","TP53 K132 missense","TP53, K132N",1,0,0,"None",0,24.34
"TCGA-OR-A5KO","ZNRF3_mut",80,39,"Stage IV",17.77,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",46.45,"0:LIVING","Female",9,1,0,"ACC","TCGA-OR-A5KO-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1120,0.9517,"NO",105,TRUE,"ACC","1F0390FB-B267-43A2-BA5C-5BB41850E3F8","TCGA-OR-A5KO.B9C848FD-453C-4A56-B625-C4C680790D6A.pdf","B9C848FD-453C-4A56-B625-C4C680790D6A","Primary",1,"Matched",3.5,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1414,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/5/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2009,"Right",NA,NA,NA,"Biopsy Proven|Imaging Suspected",NA,"Liver",NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","B4B41A43-EE45-4AA3-ABF0-100DB752A6AC","N0","T4","YES",NA,"YES",NA,NA,"NO",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present","TP53","E339*","TP53 truncating","TP53, E339*",1,0,0,"Cortisol",0,46.45
"TCGA-OR-A5KP",NA,80,45,"Stage II",41.06,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",91.23,"0:LIVING","Female",6,1,0,"ACC","TCGA-OR-A5KP-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2281,0.4946,"NO",112,TRUE,"ACC","C686ABC9-5DBD-4694-8988-7995BDF53798","TCGA-OR-A5KP.C07E8EA7-A221-40F9-9D19-A59DE0E52200.pdf","C07E8EA7-A221-40F9-9D19-A59DE0E52200","Primary",1,"Matched",3.73333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",2549,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","6/27/14","Both Clinical and Biochemical Assessments","No","Yes","C74.0","8370/3","C74.0","YES",2006,"Left",2,"YES",0,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","YES","Nuclear Grade III or IV Absent","653F1D34-73E9-4216-B40B-E25C1CFC7943","N0","T2","YES",NA,"YES",NA,NA,"YES",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",0,91.23
"TCGA-OR-A5KQ",NA,60,20,"Stage II",87.94,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen|Mineralocorticoids",87.94,"0:LIVING","Female",3,0,0,"ACC","TCGA-OR-A5KQ-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2490,0.011,"NO",71,TRUE,"ACC","EE6F808D-BBD6-4E44-B17B-0F6673A6364F","TCGA-OR-A5KQ.7ED6314A-1343-47D5-A40D-4B53FA3D33DF.pdf","7ED6314A-1343-47D5-A40D-4B53FA3D33DF","Primary",1,"Matched",2.33333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",2251,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","6/26/14","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2006,"Right",NA,NA,NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent","NO","Nuclear Grade III or IV Present","A3383252-1161-4B65-8BAC-125A6EDA3D08","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Androgen+Mineralocorticoids",0,87.94
"TCGA-OR-A5KS",NA,120,72,"Stage II",83.74,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",83.74,"0:LIVING","Male",NA,0,0,"ACC","TCGA-OR-A5KS-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2425,0.7834,"NO",91,TRUE,"ACC","67924E9C-059B-4C9C-861E-4C33E9BF5D57","TCGA-OR-A5KS.CF5CAAE7-CEA0-4505-A33F-7E7588DB7D7C.pdf","CF5CAAE7-CEA0-4505-A33F-7E7588DB7D7C","Primary",1,"Matched",3.03333333333,"A",NA,NA,"M0","No imaging evidence of disease","YES",NA,2549,0,NA,"NOT HISPANIC OR LATINO","6/26/14",NA,"No","No","C74.0","8370/1","C74.0","YES",2006,"Left",NA,"NO",NA,NA,NA,NA,0,NA,"NO","Necrosis Present","NO",NA,"11D8A9C2-14D8-4FC2-8388-386051E408B1","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR","Complete Remission/Response","TUMOR FREE",NA,NA,NA,NA,NA,0,0,0,"None",0,83.74
"TCGA-OR-A5KT","wt",80,44,"Stage I",68.96,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",95.11,"0:LIVING","Female",2,1,0,"ACC","TCGA-OR-A5KT-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2399,0.0818,"NO",54,TRUE,"ACC","92522F10-7730-4B1C-8916-428E86DA1D4F","TCGA-OR-A5KT.7BE65565-0C63-466C-AE5D-A9B47BB354C9.pdf","7BE65565-0C63-466C-AE5D-A9B47BB354C9","Primary",1,"Matched",1.83333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",2673,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","4/2/14","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2006,"Left",NA,NA,NA,NA,NA,NA,1,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","YES","Nuclear Grade III or IV Absent","DE7F06AA-9638-4389-AC8E-711ADFA0F2A5","N0","T1",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",0,95.11
"TCGA-OR-A5KU","CTNNB1_mut",70,37,"Stage II",153.52,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Mineralocorticoids",153.52,"0:LIVING","Female",2,0,0,"ACC","TCGA-OR-A5KU-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4543,0.9327,"NO",81,TRUE,"ACC","EFBCD3A5-723A-4361-9769-C01336F5F22D","TCGA-OR-A5KU.F9F537ED-3066-4E99-B6D1-112D6C4551F0.pdf","F9F537ED-3066-4E99-B6D1-112D6C4551F0","Primary",1,"Matched",2.7,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",4673,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/5/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/1","C74.0","YES",2000,"Left",1,"YES",0,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","NO","Nuclear Grade III or IV Absent","424A497A-48B9-4507-B234-C4FD08C8ACAD","N0","T2","YES",NA,"YES",NA,"NO",NA,NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Mineralocorticoids",0,153.52
"TCGA-OR-A5KV","wt",50,17,"Stage III",36.66,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",127.4,"0:LIVING","Female",3,0,0,"ACC","TCGA-OR-A5KV-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",3429,0.0053,"NO",83,TRUE,"ACC","76F9ABF7-01AB-48BE-A7BB-23ADDDBCACF8","TCGA-OR-A5KV.D85CC5BA-0A85-4BCB-8088-9EBA37211501.pdf","D85CC5BA-0A85-4BCB-8088-9EBA37211501","Primary",1,"Matched",2.73333333333,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Absent",3659,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/5/13","Biochemical Assessment","No","No","C74.0","8370/3","C74.0","YES",2003,"Left",1,"YES",1,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","202F7A77-9E5A-4F12-8FFE-78AE5527A746","N1","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","YES","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Androgen+Cortisol",0,127.4
"TCGA-OR-A5KW","ZNRF3_mut",230,55,"Stage III",68.2,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",68.2,"0:LIVING","Female",NA,0,0,"ACC","TCGA-OR-A5KW-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1245,1,"NO",79,TRUE,"ACC","0A8E38A4-7E21-4A7A-A0D4-47455F1DB4CF","TCGA-OR-A5KW.751F5B53-9186-4602-B824-8593E63EAC3F.pdf","751F5B53-9186-4602-B824-8593E63EAC3F","Primary",1,"Matched",2.63333333333,"A",NA,NA,"M0","No imaging evidence of disease","YES",NA,1525,0,NA,"NOT HISPANIC OR LATINO","11/7/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2009,"Right",9,"YES",8,NA,NA,NA,10,NA,"NO",NA,"NO",NA,"69F4F19C-08C8-4001-92A8-FED155C3B4FE","N1","T2","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR","Complete Remission/Response","TUMOR FREE",NA,NA,NA,NA,NA,0,0,0,"Androgen+Cortisol",0,68.2
"TCGA-OR-A5KX","wt",190,25,"Stage III",2.04,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type",NA,44.81,"0:LIVING","Female",7,1,0,"ACC","TCGA-OR-A5KX-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",914,0.2884,"NO",80,TRUE,"ACC","57C08142-B394-49CB-A613-910A2264514E","TCGA-OR-A5KX.02EBE0C2-AE20-4F08-81E7-3EC45E12C0F4.pdf","02EBE0C2-AE20-4F08-81E7-3EC45E12C0F4","Primary",1,"Matched",2.66666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1091,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/6/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2010,"Left",NA,"YES",NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","33C02ECE-911B-4F45-B410-9DF07E9B189E","N1","T2","YES",NA,"YES",NA,NA,"NO",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,NA,0,44.81
"TCGA-OR-A5KY","ZNRF3_mut",120,23,"Stage IV",6.01,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",12.84,"1:DECEASED","Female",3,1,1,"ACC","TCGA-OR-A5KY-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",939,0.3886,"NO",94,TRUE,"ACC","FF35CA1E-064F-4C89-9BBE-01D26C5C57BF","TCGA-OR-A5KY.23328F06-11F8-4D12-BA95-D5CC9AEFE22A.pdf","23328F06-11F8-4D12-BA95-D5CC9AEFE22A","Primary",1,"Matched",3.1,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/5/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2010,"Left",52,"YES",52,"Imaging Suspected",NA,"Bone|Lung|Peritoneum",5,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent","YES","Nuclear Grade III or IV Absent","5F461197-15ED-43CF-9331-9E0EFC4622A4","N1","T4","NO","YES","YES","NO",NA,NA,"YES","YES","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Absent","TP53","C135Y","TP53 C135 missense","TP53, C135Y",1,1,0,"Androgen+Cortisol",1,12.84
"TCGA-OR-A5KZ","ZNRF3_mut",120,42,"Stage II",1.18,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",4.11,"1:DECEASED","Male",8,1,1,"ACC","TCGA-OR-A5KZ-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",319,0.4502,"NO",79,TRUE,"ACC","0C9C6928-BA38-49DA-A5CF-67DD8E038F60","TCGA-OR-A5KZ.22298C81-A72D-4E22-99DD-6541FB0953A4.pdf","22298C81-A72D-4E22-99DD-6541FB0953A4","Primary",1,"Matched",2.56666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","Persistent locoregional disease","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/7/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2012,"Left",NA,NA,NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","99F86B57-3894-45C5-BFBE-C757C69A3050","N0","T2","YES",NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","RX",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present","TP53","E180_D184del",NA,"TP53, E180_D184del",1,-1,1,"Cortisol",1,4.11
"TCGA-OR-A5L1",NA,160,37,"Stage II",22.5,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",58.51,"0:LIVING","Female",NA,0,0,"ACC","TCGA-OR-A5L1-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4424,0.7841,"NO",52,TRUE,"ACC","8452F144-76C0-4223-A7E9-A81AD9EA85F4","TCGA-OR-A5L1.914A8783-5ACF-4580-A663-E73BDDAA7286.pdf","914A8783-5ACF-4580-A663-E73BDDAA7286","Primary",1,"Matched",1.73333333333,"A",NA,NA,"M0",NA,"YES",NA,1781,0,NA,"NOT HISPANIC OR LATINO","6/27/14","Biochemical Assessment","No","No","C74.0","8370/3","C74.0","YES",2000,"Left",NA,"NO",NA,NA,NA,NA,NA,NA,"NO","Necrosis Present","YES",NA,"3ED33021-8EFD-420F-9A0B-E7420B586BCD","N0","T2","YES",NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR","Complete Remission/Response","WITH TUMOR",NA,NA,NA,NA,NA,0,0,0,"Cortisol",0,58.51
"TCGA-OR-A5L2",NA,110,83,"Stage II",NA,NA,"Adrenocortical carcinoma- Usual Type",NA,60.84,"1:DECEASED","Female",NA,1,0,"ACC","TCGA-OR-A5L2-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4313,0.3586,"NO",191,TRUE,"ACC","65D78B08-0B5C-415B-A4E3-41111EB42C09","TCGA-OR-A5L2.A3E8E475-D5A7-4A4C-AA1D-3B3AE50F572B.pdf","A3E8E475-D5A7-4A4C-AA1D-3B3AE50F572B","Primary",1,"Matched",6.4,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES",NA,NA,0,NA,"NOT HISPANIC OR LATINO","6/26/14",NA,"No","No","C74.0","8370/1","C74.0","YES",2001,"Left",NA,"NO",NA,NA,NA,NA,30,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO",NA,"A26B6F97-FD7E-4B96-BDF5-9DF4F9233726","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR","Complete Remission/Response","TUMOR FREE",NA,NA,NA,NA,NA,0,-1,1,NA,1,60.84
"TCGA-OR-A5L3","CTNNB1_mut",70,67,"Stage I",152.04,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Cortisol",152.04,"0:LIVING","Female",3,0,0,"ACC","TCGA-OR-A5L3-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",4591,0.0364,"NO",62,TRUE,"ACC","FC7AA029-F103-41FB-ADD3-DD6070A13DAF","TCGA-OR-A5L3.FE1CF238-753C-4DF4-A083-74DDC753DF45.pdf","FE1CF238-753C-4DF4-A083-74DDC753DF45","Primary",1,"Matched",2.13333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Absent",3897,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/5/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2000,"Right",NA,NA,NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","A9A57127-94D3-425F-A4C5-5CBCF24A9A35","N0","T1",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Cortisol",0,152.04
"TCGA-OR-A5L4","wt",80,48,"Stage III",31.77,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",31.77,"0:LIVING","Female",7,0,0,"ACC","TCGA-OR-A5L4-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",456,0.9478,"NO",62,TRUE,"ACC","3BE50768-A2B0-4498-A5E8-D5BA86E8680C","TCGA-OR-A5L4.B140F5B4-5B03-40EC-A5BB-BCF0963EC567.pdf","B140F5B4-5B03-40EC-A5BB-BCF0963EC567","Primary",1,"Matched",2.1,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",724,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","4/2/14","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2011,"Right",NA,NA,NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","905368C2-BA60-4DDA-B32D-A51A203B5E4D","N0","T4","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","NO","RX",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,0,0,"Androgen+Cortisol",0,31.77
"TCGA-OR-A5L5","wt",70,77,"Stage I",43.27,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen|Estrogen",43.27,"0:LIVING","Female",4,0,0,"ACC","TCGA-OR-A5L5-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",828,0.1875,"NO",85,TRUE,"ACC","321A91CE-7CC6-49E0-9E50-130DB43DB7F5","TCGA-OR-A5L5.A1989B2E-FB1F-420A-BF11-2C79F3E81884.pdf","A1989B2E-FB1F-420A-BF11-2C79F3E81884","Primary",1,"Matched",2.86666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Absent",840,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/6/13","Biochemical Assessment","No","Yes","C74.0","8370/3","C74.0","YES",2010,"Left",NA,"NO",NA,NA,NA,NA,15,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","2F04E760-8A64-49F2-A1D6-3D390604745C","N0","T1",NA,NA,"NO",NA,NA,NA,NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,NA,"Adrenal","OR","Complete Remission/Response","TUMOR FREE",NA,NA,NA,NA,NA,0,0,0,"Androgen+Estrogen",0,43.27
"TCGA-OR-A5L6","wt",80,60,"Stage II",28.29,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen",28.29,"0:LIVING","Male",7,1,0,"ACC","TCGA-OR-A5L6-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",433,0.38,"NO",85,TRUE,"ACC","0F19F2D5-D552-4F7A-88D8-BB559CB1CD0F","TCGA-OR-A5L6.6104CA0C-86CD-46C9-A111-0024A75FB727.pdf","6104CA0C-86CD-46C9-A111-0024A75FB727","Primary",1,"Matched",2.83333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",628,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/5/13","Biochemical Assessment","No","No","C74.0","8370/3","C74.0","YES",2011,"Left",NA,NA,NA,NA,NA,NA,23,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","F13A3D5E-7F8E-4ACB-AD46-F6380A9443E8","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Androgen",0,28.29
"TCGA-OR-A5L8","CTNNB1_mut",70,36,"Stage II",29.07,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Mineralocorticoids|Cortisol",29.07,"0:LIVING","Female",4,0,0,"ACC","TCGA-OR-A5L8-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",558,0.9477,"NO",83,TRUE,"ACC","EBFAAAE3-9A83-498D-AA97-7CF19208D2DA","TCGA-OR-A5L8.C4BBFD0B-83D0-47C8-9662-13691FE6D820.pdf","C4BBFD0B-83D0-47C8-9662-13691FE6D820","Primary",1,"Matched",2.7,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",555,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/4/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2011,"Right",NA,"NO",NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent","NO","Nuclear Grade III or IV Absent","5E086192-AB74-4AA3-BF6B-B34AB19995DB","N0","T2","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,0,0,"Mineralocorticoids+Cortisol",0,29.07
"TCGA-OR-A5L9","wt",10,53,"Stage II",28.61,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen",28.61,"0:LIVING","Female",3,0,0,"ACC","TCGA-OR-A5L9-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",457,0.2282,"NO",70,TRUE,"ACC","810B23D4-B8D6-41E3-8BC1-A46AA201453C","TCGA-OR-A5L9.09FD99AA-10FF-4E45-9B21-2B3F7D846758.pdf","09FD99AA-10FF-4E45-9B21-2B3F7D846758","Primary",1,"Matched",2.36666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",645,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/4/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/1","C74.0","YES",2011,"Right",5,"YES",0,NA,NA,NA,5,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","C6312DE5-DD56-4025-80D1-DBDD8568D047","N0","T2","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR",NA,"TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Androgen",0,28.61
"TCGA-OR-A5LA","wt",60,52,"Stage II",23.62,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",23.62,"0:LIVING","Female",5,0,0,"ACC","TCGA-OR-A5LA-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",208,0.8855,"NO",57,TRUE,"ACC","B3447E85-1D34-4FB0-8F08-03B9EA98FA0A","TCGA-OR-A5LA.68F5B84D-8967-4A77-B5D9-65526AB9FFBB.pdf","68F5B84D-8967-4A77-B5D9-65526AB9FFBB","Primary",1,"Matched",1.93333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",487,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/6/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2012,"Left",NA,"NO",NA,NA,NA,NA,1,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","E93CA89F-CA48-43CA-BF1C-ADC7491C0FE5","N0","T2","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,23.62
"TCGA-OR-A5LB","ZNRF3_mut",40,59,"Stage IV",20.07,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen",39.55,"1:DECEASED","Male",4,1,1,"ACC","TCGA-OR-A5LB-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2386,0.9468,"NO",329,TRUE,"ACC","ED5579D8-352E-4586-AC94-5320E357E9FC","TCGA-OR-A5LB.09038444-9BE4-443C-8FEC-07903972F305.pdf","09038444-9BE4-443C-8FEC-07903972F305","Primary",1,"Matched",11,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M1","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Absent",NA,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/4/13","Biochemical Assessment","No","Yes","C74.0","8370/3","C74.0","YES",2006,"Right",NA,"NO",NA,"Other, specify","Operation","Liver|Other, specify",8,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Absent","YES","Nuclear Grade III or IV Absent","FB504E55-1859-48EE-AEC7-A3FCB082785E","N0","T4",NA,"YES","YES","YES",NA,NA,"YES","YES","NO","WHITE","YES","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Androgen",1,39.55
"TCGA-OR-A5LC","ZNRF3_mut",20,71,"Stage IV",1.64,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",5.22,"1:DECEASED","Female",3,1,1,"ACC","TCGA-OR-A5LC-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",730,0.7058,"NO",103,TRUE,"ACC","30A81B5B-E706-49F8-BF69-A6C77DC3A317","TCGA-OR-A5LC.CE74A15F-B71A-483D-BDD2-C47413E4DABB.pdf","CE74A15F-B71A-483D-BDD2-C47413E4DABB","Primary",1,"Matched",3.5,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Absent",NA,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/4/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2011,"Left",NA,NA,NA,"Biopsy Proven|Imaging Suspected",NA,"Bone|Liver",NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","YES","Nuclear Grade III or IV Absent","F8954241-E541-406F-A09D-C3C987473732","N0","T4",NA,"YES","YES",NA,NA,NA,"NO","YES","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Cortisol",1,5.22
"TCGA-OR-A5LD","wt",200,52,"Stage III",14.59,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",39.32,"1:DECEASED","Male",5,0,1,"ACC","TCGA-OR-A5LD-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",5280,0.4517,"NO",86,TRUE,"ACC","5FE9FDB5-F6F9-40DA-8CC8-413C4305E86A","TCGA-OR-A5LD.08D3F046-01AD-40B2-A4EC-1121366614CA.pdf","08D3F046-01AD-40B2-A4EC-1121366614CA","Primary",1,"Matched",2.83333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/7/13",NA,"No","No","C74.0","8370/3","C74.0","YES",1998,"Left",NA,"NO",NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Absent","D885B720-E813-4828-A731-B3CDCBD20687","N0","T4",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","RX",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",1,39.32
"TCGA-OR-A5LE","CTNNB1_mut",50,14,"Stage II",8.71,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type",NA,21.75,"1:DECEASED","Male",5,1,1,"ACC","TCGA-OR-A5LE-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",5587,0.1961,"NO",87,TRUE,"ACC","3515D365-BE8A-496B-80D1-ABBDAF0F23F1","TCGA-OR-A5LE.5F38424F-73C9-41F5-B183-6A812A65593A.pdf","5F38424F-73C9-41F5-B183-6A812A65593A","Primary",1,"Matched",2.9,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/4/13",NA,"No","No","C74.0","8370/3","C74.0","YES",1997,"Left",NA,"YES",NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","C4DD9501-C193-45FB-8535-A9D901520BDD","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR",NA,"WITH TUMOR","Venous Invasion Absent","TP53","P27Lfs*17","TP53 truncating","TP53, P27Lfs*17",1,-1,1,NA,1,21.75
"TCGA-OR-A5LF",NA,110,74,"Stage III",NA,NA,"Adrenocortical carcinoma- Usual Type","None",14.62,"1:DECEASED","Female",5,0,1,"ACC","TCGA-OR-A5LF-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",3880,0.8306,"NO",80,TRUE,"ACC","0B547426-8D18-42DB-9832-91D5CBA7C370","TCGA-OR-A5LF.1E988E48-9FF4-4355-89CE-410CC1964D6C.pdf","1E988E48-9FF4-4355-89CE-410CC1964D6C","Primary",1,"Matched",2.66666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","6/27/14",NA,"No","No","C74.0","8370/3","C74.0","YES",2002,"Left",NA,"NO",NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Absent","NO","Nuclear Grade III or IV Absent","7E61E3B8-C617-4A5F-AFDF-689521C9A670","N0","T3",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,0,0,"None",1,14.62
"TCGA-OR-A5LG","wt",180,46,"Stage III",45.76,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",52.2,"0:LIVING","Male",6,0,0,"ACC","TCGA-OR-A5LG-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1667,0.2283,"NO",99,TRUE,"ACC","D2D69DF9-E7EB-4F4C-84CE-CDF150BE8503","TCGA-OR-A5LG.DA704AB1-8D08-48EC-9F62-A6B5E69E4DC7.pdf","DA704AB1-8D08-48EC-9F62-A6B5E69E4DC7","Primary",1,"Matched",3.26666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1589,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/5/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2008,"Left",1,"YES",0,NA,NA,"Liver",NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Absent","YES","Nuclear Grade III or IV Present","FAD4B7E6-510C-4968-83DF-3140ED5A0549","N0","T3","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO","WHITE","NO","RX",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Cortisol",0,52.2
"TCGA-OR-A5LH","wt",130,36,"Stage II",NA,NA,"Adrenocortical carcinoma- Usual Type","Androgen",78.35,"1:DECEASED","Female",3,0,0,"ACC","TCGA-OR-A5LH-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2731,0.4853,"NO",83,TRUE,"ACC","F9C01615-0645-4D26-84E4-C5D55D9C9566","TCGA-OR-A5LH.093D8D72-8D1B-4C23-A132-D0DCBB05DE26.pdf","093D8D72-8D1B-4C23-A132-D0DCBB05DE26","Primary",1,"Matched",2.7,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M0","Persistent distant metastases","YES","Cytoplasm presence <= 25% Absent",NA,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","11/5/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2005,"Left",NA,"NO",NA,NA,NA,NA,5,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","NO","Nuclear Grade III or IV Absent","CF327482-199B-4604-AC19-C8B68D91C5D9","N0","T2","YES",NA,"YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Androgen",1,78.35
"TCGA-OR-A5LI",NA,110,42,"Stage IV",2,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",14.32,"1:DECEASED","Female",6,1,1,"ACC","TCGA-OR-A5LI-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",5353,0.3512,"NO",144,TRUE,"ACC","E4BF6516-5305-4917-B278-F3C993884758","TCGA-OR-A5LI.087A53B3-572F-4492-8D19-7CFE41C8DA39.pdf","087A53B3-572F-4492-8D19-7CFE41C8DA39","Primary",1,"Matched",4.76666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","6/26/14","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",1998,"Right",NA,"NO",NA,"Imaging Suspected",NA,"Lung",NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","EC9C3EFE-AF61-4DEB-B047-DCF7EE735FD2","N0","T4",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",1,14.32
"TCGA-OR-A5LJ","CTNNB1_mut",110,54,"Stage IV",3.22,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",36.3,"1:DECEASED","Female",8,1,1,"ACC","TCGA-OR-A5LJ-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2633,0.9476,"NO",542,TRUE,"ACC","6DD9DD3B-F1FF-4ADE-B7B0-2FF7ACA52CA8","TCGA-OR-A5LJ.B93073AF-A15A-4BAB-AC70-E16D89256DFC.pdf","B93073AF-A15A-4BAB-AC70-E16D89256DFC","Primary",1,"Matched",18.0666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","11/7/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2005,"Left",NA,"YES",NA,"Imaging Suspected",NA,"Lung|Other, specify",10,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","FC83AB27-929E-4AD4-BA18-ABB0694F1E43","N1","T2","YES","YES","YES",NA,NA,NA,NA,"YES","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Progressive Disease","WITH TUMOR","Venous Invasion Present","TP53","R213*","TP53 truncating","TP53, R213*",1,0,0,"Androgen+Cortisol",1,36.3
"TCGA-OR-A5LK","wt",120,62,"Stage II",90.01,"0:DiseaseFree","Adrenocortical Carcinoma- Oncocytic Type","None",90.01,"0:LIVING","Male",5,0,0,"ACC","TCGA-OR-A5LK-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",2096,0.9999,"NO",94,TRUE,"ACC","FE5D3E56-2D21-49FD-8818-68E8FB24E51B","TCGA-OR-A5LK.4917D13C-6355-4E4B-8189-FE4443313F53.pdf","4917D13C-6355-4E4B-8189-FE4443313F53","Primary",1,"Matched",3.13333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",2222,0,"Diffuse Architecture Present",NA,"11/27/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2007,"Right",NA,"NO",NA,NA,NA,NA,7,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","9C87DCEE-D422-4DF1-82E1-3FA201473E31","N0","T2","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,90.01
"TCGA-OR-A5LL","wt",180,75,"Stage II",7,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",52.99,"1:DECEASED","Female",7,1,1,"ACC","TCGA-OR-A5LL-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1882,0.3624,"NO",78,TRUE,"ACC","C32A896A-BC08-455C-8E01-C75FAE985A56","TCGA-OR-A5LL.A898F0C7-9596-4DF1-9784-CAACFAB672D8.pdf","A898F0C7-9596-4DF1-9784-CAACFAB672D8","Primary",1,"Matched",2.6,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present",NA,"11/27/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2007,"Right",10,"YES",0,NA,NA,NA,15,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","0304B12D-7640-4150-A581-2EEA2B1F2AD5","N0","T2","YES","NO","YES",NA,"YES","YES",NA,"YES","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",1,52.99
"TCGA-OR-A5LM",NA,120,23,"Stage II",61.04,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Estrogen",61.04,"0:LIVING","Male",7,NA,0,"ACC","TCGA-OR-A5LM-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1821,0.6798,"NO",NA,TRUE,"ACC","6F41AF90-80F5-4032-A323-59204CB30567","TCGA-OR-A5LM.57A7E2E6-210B-41B1-8C22-9ED4930BCDEA.pdf","57A7E2E6-210B-41B1-8C22-9ED4930BCDEA","Primary",1,"Matched",NA,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1858,0,"Diffuse Architecture Present",NA,"11/27/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2008,"Right",32,"YES",0,NA,NA,NA,18,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","E612EF6E-F3F2-44BE-AB15-8E4095687CD6","N0","T2","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,NA,NA,NA,"Estrogen",0,61.04
"TCGA-OR-A5LN","wt",120,31,"Stage II",76.94,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",76.94,"0:LIVING","Female",6,0,0,"ACC","TCGA-OR-A5LN-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1790,0.652,"NO",71,TRUE,"ACC","3A56DF78-5E32-4E8A-9B69-23CB8F781368","TCGA-OR-A5LN.92EE5592-2CEC-4F7C-BF7B-A0A2CEE5E169.pdf","92EE5592-2CEC-4F7C-BF7B-A0A2CEE5E169","Primary",1,"Matched",2.4,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1916,0,"Diffuse Architecture Present",NA,"11/27/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2008,"Right",10,"YES",0,NA,NA,NA,6,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Absent","NO","Nuclear Grade III or IV Present","56CDBBA2-327E-4ACD-A1EB-0F313A77834F","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,76.94
"TCGA-OR-A5LO","ZNRF3_mut",170,61,"Stage II",5.03,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Estrogen",79.01,"1:DECEASED","Female",7,0,0,"ACC","TCGA-OR-A5LO-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1700,0.9315,"NO",117,TRUE,"ACC","55EE2B0E-FEFF-4F93-982A-5B64820B7A34","TCGA-OR-A5LO.45C2478C-53EF-4422-A9EF-33C40A3AA275.pdf","45C2478C-53EF-4422-A9EF-33C40A3AA275","Primary",1,"Matched",3.9,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1949,0,"Diffuse Architecture Present",NA,"11/27/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2008,"Right",19,"YES",0,NA,NA,NA,12,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","1D5602A7-72E7-4DC6-B2DB-2F778FCBF475","N0","T2","YES",NA,"YES",NA,"YES","YES",NA,"YES","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,1,0,"Androgen+Estrogen",1,79.01
"TCGA-OR-A5LP","wt",120,37,"Stage II",61.01,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",61.01,"0:LIVING","Female",5,0,0,"ACC","TCGA-OR-A5LP-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1396,0.2488,"NO",60,TRUE,"ACC","E2771D70-C65E-4F0A-8207-0589DCCB36A3","TCGA-OR-A5LP.FCD998EA-2EEA-4A94-80A6-D87F962BBC87.pdf","FCD998EA-2EEA-4A94-80A6-D87F962BBC87","Primary",1,"Matched",1.96666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",1583,0,"Diffuse Architecture Present",NA,"11/27/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2009,"Right",21,"YES",0,NA,NA,NA,0,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Absent","NO","Nuclear Grade III or IV Present","DFEF51C8-6050-4EBB-B25C-E74919397244","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"None",0,61.01
"TCGA-OR-A5LR","wt",50,30,"Stage II",28.02,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Mineralocorticoids",28.02,"0:LIVING","Female",7,0,0,"ACC","TCGA-OR-A5LR-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",482,0.227,"NO",48,TRUE,"ACC","2951751D-B9D1-4D07-9E2B-7398B5B8CFD5","TCGA-OR-A5LR.A1C555F3-4513-45C6-9A39-968902130B94.pdf","A1C555F3-4513-45C6-9A39-968902130B94","Primary",1,"Matched",1.6,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",639,0,"Diffuse Architecture Present",NA,"11/26/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2011,"Left",NA,"NO",NA,NA,NA,NA,6,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","723EB689-7B4F-4758-BCDF-426B12508935","N0","T2","YES",NA,"YES",NA,NA,"NO",NA,"YES","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,0,0,"Mineralocorticoids",0,28.02
"TCGA-OR-A5LS","ZNRF3_mut",100,34,"Stage II",36.01,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",36.01,"0:LIVING","Female",6,1,0,"ACC","TCGA-OR-A5LS-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",725,0.9255,"NO",117,TRUE,"ACC","3636FA2C-4AD1-4ACB-9C51-6C52972DEB18","TCGA-OR-A5LS.31004530-E017-4913-A8AA-7AE709EAE0F1.pdf","31004530-E017-4913-A8AA-7AE709EAE0F1","Primary",1,"Matched",3.83333333333,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",882,0,"Diffuse Architecture Absent",NA,"11/27/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2011,"Right",NA,"NO",NA,NA,NA,NA,7,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","F63946EC-DDCB-469A-8F5E-74366B7F419B","N0","T2","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,-1,1,"Androgen+Cortisol",0,36.01
"TCGA-OR-A5LT","wt",160,57,"Stage III",18.04,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",18.04,"0:LIVING","Male",8,0,0,"ACC","TCGA-OR-A5LT-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",178,0.7957,"NO",76,TRUE,"ACC","AAD9042B-4A86-4D03-9EC7-A8A4494F6F56","TCGA-OR-A5LT.6C9B7DE2-682F-4F4A-8879-159F9989C40C.pdf","6C9B7DE2-682F-4F4A-8879-159F9989C40C","Primary",1,"Matched",2.56666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",365,0,"Diffuse Architecture Present",NA,"11/27/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2012,"Left",18,"YES",0,NA,NA,NA,10,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","NO","Nuclear Grade III or IV Present","15FB07AE-101C-4553-891D-539CEE89A5E9","N0","T3","YES",NA,"YES",NA,"NO","YES",NA,"YES","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","OR","Complete Remission/Response","TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,1,0,"None",0,18.04
"TCGA-OU-A5PI","ZNRF3_mut",160,53,"Stage IV",11.53,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","None",38.47,"0:LIVING","Female",2,1,0,"ACC","TCGA-OU-A5PI-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",577,0.9476,"NO",93,FALSE,"ACC","7BBF0A45-A675-4F05-AC45-9E92BA55D542","TCGA-OU-A5PI.2AA8FA9B-A202-48AB-A543-6E0B1B45B1D4.pdf","2AA8FA9B-A202-48AB-A543-6E0B1B45B1D4","Primary",1,"Matched",3.06666666667,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Absent",709,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","7/16/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2011,"Left",3,"YES",3,"Other, specify","Resection","Lung",NA,"Mitotic Rate > 5/50 HPF Absent","YES","Necrosis Present","YES","Nuclear Grade III or IV Absent","A5BE4E42-CB6C-4E67-8547-45DBD058BB95","N1","T2","YES","NO","YES",NA,NA,NA,NA,"YES","NO","WHITE","NO",NA,"RET Negative","YES",1,"Sinusoid Invasion Absent","Adrenal","OU","Stable Disease","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,0,-1,1,"None",0,38.47
"TCGA-P6-A5OF",NA,200,55,"Stage III",4.7,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",6.8,"1:DECEASED","Female",4,NA,1,"ACC","TCGA-P6-A5OF-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",930,NA,"NO",54,FALSE,"ACC","42E0C347-E8D1-4490-A6BB-8A43E5A21013","TCGA-P6-A5OF.D03F4355-72A4-4CDF-B7BE-DDB016D69A90.pdf","D03F4355-72A4-4CDF-B7BE-DDB016D69A90","Primary",1,"Matched",1.8,"A",NA,NA,"M0","Persistent distant metastases","YES",NA,NA,0,NA,"NOT HISPANIC OR LATINO","8/15/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2010,"Right",NA,"NO",NA,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Present","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","888A7158-2319-4563-849B-573705C72AB7","N0","T4",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","RX",NA,"YES",1,NA,"Adrenal","P6",NA,"WITH TUMOR","Venous Invasion Present",NA,NA,NA,NA,NA,NA,NA,"Androgen+Cortisol",1,6.8
"TCGA-P6-A5OG",NA,200,45,"Stage IV",0.36,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Cortisol",12.58,"1:DECEASED","Female",4,NA,1,"ACC","TCGA-P6-A5OG-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",426,0.1246,"NO",NA,FALSE,"ACC","AF208939-BAE3-4CB8-9AD3-F799C38FC1C0","TCGA-P6-A5OG.4F591001-D8B2-4B68-A219-45EBA6903A80.pdf","4F591001-D8B2-4B68-A219-45EBA6903A80","Primary",1,"Matched",NA,"A","Atypical Mitotic Figures Absent","Invasion of Tumor Capsule Present","M1","Persistent distant metastases","YES","Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Absent","NOT HISPANIC OR LATINO","8/15/13","Biochemical Assessment","No","Yes","C74.0","8370/3","C74.0","YES",2011,"Left",6,"YES",0,"Biopsy Proven",NA,"Liver",NA,"Mitotic Rate > 5/50 HPF Absent","NO","Necrosis Present","YES","Nuclear Grade III or IV Present","0824B246-9FA2-4A8B-AD4C-1FFC7731BF7D","N0","T4",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R2",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","P6","Complete Remission/Response","WITH TUMOR","Venous Invasion Absent",NA,NA,NA,NA,NA,NA,NA,"Cortisol",1,12.58
"TCGA-P6-A5OH",NA,200,59,"Stage IV",NA,NA,"Adrenocortical carcinoma- Usual Type",NA,0,"1:DECEASED","Female",4,1,1,"ACC","TCGA-P6-A5OH-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",1021,0.4477,"NO",219,FALSE,"ACC","E9FC10AF-598A-4B10-84B0-C77131DAAE5B","TCGA-P6-A5OH.349F5609-E653-4CF0-B63C-AF01D68D40E7.pdf","349F5609-E653-4CF0-B63C-AF01D68D40E7","Primary",1,"Matched",7.33333333333,"A",NA,NA,"M1",NA,NA,"Cytoplasm presence <= 25% Present",NA,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","3/25/14",NA,"No","No","C74.0","8370/3","C74.0","YES",2010,"Right",NA,NA,NA,"Biopsy Proven",NA,"Liver",NA,NA,"NO","Necrosis Present","NO","Nuclear Grade III or IV Present","92B67CA9-6C82-463E-9CC5-685A1D02EA3E","N0","T4",NA,NA,"NO",NA,NA,NA,NA,"NO","NO","WHITE","NO","R2",NA,"YES",1,NA,"Adrenal","P6",NA,"WITH TUMOR",NA,NA,NA,NA,NA,0,-1,1,NA,1,0
"TCGA-PA-A5YG","wt",440,51,"Stage II",24.84,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type",NA,24.84,"0:LIVING","Male",NA,0,0,"ACC","TCGA-PA-A5YG-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",85,0.2575,"NO",48,TRUE,"ACC","057592A6-CD78-4F54-8017-8532DDA3FE3E","TCGA-PA-A5YG.9C523464-BFDB-4C7A-972E-2EBECDBBFF3E.pdf","9C523464-BFDB-4C7A-972E-2EBECDBBFF3E","Primary",1,"Matched",1.6,"A",NA,NA,"M0","No imaging evidence of disease","YES",NA,470,0,NA,"NOT HISPANIC OR LATINO","4/7/14",NA,"No","No","C74.0","8370/3","C74.0","YES",2012,"Left",NA,"NO",NA,NA,NA,NA,NA,NA,"NO",NA,"NO",NA,"8B3649E3-16E2-4044-8AB8-F4D28A87E513","N0","T2",NA,NA,"NO",NA,NA,NA,NA,"NO","YES","WHITE","NO","R0",NA,"NO",1,NA,"Adrenal","PA","Complete Remission/Response","TUMOR FREE",NA,NA,NA,NA,NA,0,0,0,NA,0,24.84
"TCGA-PK-A5H8",NA,210,42,"Stage II",119.02,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type",NA,119.02,"0:LIVING","Male",7,NA,0,"ACC","TCGA-PK-A5H8-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",3025,NA,"NO",51,FALSE,"ACC","8E86E6C3-10D0-423B-9448-01567222E202","TCGA-PK-A5H8.706EC715-C6CD-49A9-8993-D6E5B20AED95.pdf","706EC715-C6CD-49A9-8993-D6E5B20AED95","Primary",1,"Matched",1.7,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M0",NA,"YES","Cytoplasm presence <= 25% Present",3240,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","9/16/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2004,"Right",NA,"NO",NA,NA,NA,NA,9,"Mitotic Rate > 5/50 HPF Present",NA,"Necrosis Present","NO","Nuclear Grade III or IV Present","42EF34CC-FFB4-432C-82BB-7AA56639FF51","N0","T2",NA,NA,NA,NA,NA,NA,NA,"NO","NO","WHITE","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","PK",NA,"TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,NA,NA,NA,NA,0,119.02
"TCGA-PK-A5H9","wt",90,27,"Stage II",20.24,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","Androgen",20.24,"0:LIVING","Female",4,0,0,"ACC","TCGA-PK-A5H9-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",92,0.0107,"NO",93,FALSE,"ACC","0A0A8E16-D3AF-4E98-802E-761966588E4F","TCGA-PK-A5H9.A323FD5A-1C3E-49D3-A7EA-04E3663D6883.pdf","A323FD5A-1C3E-49D3-A7EA-04E3663D6883","Primary",1,"Matched",3.06666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Absent","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",307,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","9/16/13","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2012,"Right",NA,"NO",NA,NA,NA,NA,2,"Mitotic Rate > 5/50 HPF Absent","YES","Necrosis Absent","NO","Nuclear Grade III or IV Absent","83E7B9F8-04A4-440F-AAFC-7A8E9DDFF284","N0","T2","NO",NA,"NO",NA,NA,NA,NA,"NO","NO","ASIAN","NO","R0",NA,"YES",1,"Sinusoid Invasion Absent","Adrenal","PK",NA,"TUMOR FREE","Venous Invasion Present",NA,NA,NA,NA,0,0,0,"Androgen",0,20.24
"TCGA-PK-A5HA","wt",130,63,"Stage I",39.45,"0:DiseaseFree","Adrenocortical carcinoma- Usual Type","None",39.45,"0:LIVING","Male",8,1,0,"ACC","TCGA-PK-A5HA-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",701,0.9093,"NO",110,FALSE,"ACC","1729D2D8-5722-4579-950C-55B14167C9FD","TCGA-PK-A5HA.B98EC873-CB6D-4395-A473-C46EC4D2DB00.pdf","B98EC873-CB6D-4395-A473-C46EC4D2DB00","Primary",1,"Matched",3.66666666667,"A","Atypical Mitotic Figures Present","Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",830,0,"Diffuse Architecture Present",NA,"9/16/13",NA,"No","No","C74.0","8370/3","C74.0","YES",2011,"Left",1,"YES",0,NA,NA,NA,NA,"Mitotic Rate > 5/50 HPF Present",NA,"Necrosis Present","NO","Nuclear Grade III or IV Present","5EB5EE1F-ECFF-4427-B717-B91380C043AE","N0","T1","NO",NA,"NO",NA,NA,NA,NA,"NO","NO",NA,"NO","R0",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","PK",NA,"TUMOR FREE","Venous Invasion Absent",NA,NA,NA,NA,0,-1,1,"None",0,39.45
"TCGA-PK-A5HB","wt",70,63,NA,7,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type",NA,42.48,"0:LIVING","Male",NA,1,0,"ACC","TCGA-PK-A5HB-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",3385,0.9279,"NO",1185,FALSE,"ACC","C69DA3BD-BCDA-4627-B13A-AAE53EAB80FB","TCGA-PK-A5HB.5C732114-DD55-41D6-84C1-9BEDB7DF4345.pdf","5C732114-DD55-41D6-84C1-9BEDB7DF4345","Primary",1,"Matched",39.3,"A",NA,NA,NA,NA,NA,NA,1293,0,NA,NA,"9/16/13",NA,"No","Yes","C74.0","8370/3","C74.0","YES",2003,"Left",2,"YES",NA,NA,NA,NA,NA,NA,NA,NA,"YES",NA,"9A8EA017-0152-48B2-ACCB-D040DEB1C6B6",NA,NA,NA,NA,"NO",NA,NA,NA,NA,"YES","NO",NA,"YES",NA,NA,"YES",1,NA,"Adrenal","PK",NA,"WITH TUMOR",NA,"TP53","X307_splice","TP53 truncating","TP53, X307_splice",1,-1,1,NA,0,42.48
"TCGA-PK-A5HC",NA,120,44,"Stage III",5.49,"1:Recurred/Progressed","Adrenocortical carcinoma- Usual Type","Androgen|Cortisol",22.31,"0:LIVING","Female",NA,1,0,"ACC","TCGA-PK-A5HC-01","acc_tcga","Adrenocortical Carcinoma","Adrenocortical Carcinoma",359,0.2901,"NO",160,FALSE,"ACC","18683430-EE50-4228-A1D0-0C9DE0C0F25F","TCGA-PK-A5HC.760C639D-B101-441C-8081-30908D56EDA2.pdf","760C639D-B101-441C-8081-30908D56EDA2","Primary",1,"Matched",5.3,"A",NA,"Invasion of Tumor Capsule Present","M0","No imaging evidence of disease","YES","Cytoplasm presence <= 25% Present",679,0,"Diffuse Architecture Present","NOT HISPANIC OR LATINO","3/13/14","Both Clinical and Biochemical Assessments","No","No","C74.0","8370/3","C74.0","YES",2011,"Right",3,"YES",0,NA,NA,NA,19,"Mitotic Rate > 5/50 HPF Present",NA,"Necrosis Present","YES","Nuclear Grade III or IV Present","891B7A67-0A01-45F0-8A32-4A1B3E888F6C","N0","T4","NO",NA,"YES","YES",NA,NA,"YES","NO","NO","ASIAN","NO","R1",NA,"YES",1,"Sinusoid Invasion Present","Adrenal","PK","Complete Remission/Response","WITH TUMOR","Venous Invasion Present","TP53","V73Rfs*76","TP53 truncating","TP53, V73Rfs*76",1,1,0,"Androgen+Cortisol",0,22.31
